.png)
How AXC
Creates Value
A continuous regenerative loop where funding flows into innovation, returns flow to treasury,
and value continuously reinvests into the community and new breakthroughs
.png)
Investors
Provide capital via TT-E
TT-E SPV
Compliant fractionalized equity
Biotech / Researchers
Milestone-based research
AXC Treasury
Holds value, regenerates capital
Compassionate-Use
Mission-driven reinvestment
Community
Governance, staking, rewards
Investors
Provide capital via TT-E
TT-E SPV
Compliant fractionalized equity
Biotech / Researchers
Milestone-based research
AXC Treasury
Holds value, regenerates capital
Compassionate-Use
Mission-driven reinvestment
Community
Governance, staking, rewards
The Four-Step Value Loop
Each step feeds into the next, creating a sustainable cycle of innovation and growth
Stake AXC
Gain Governance Rights
Stake AXC to mint TT-G (Tokenized Trial Governance) NFTs, granting you governance rights to participate in curated trials. Stakers receive community benefits including eligibility for future airdrops and boosts when holding governance NFTs.
Participate in Funding
Support Vetted Trials
Fund trials with fiat currency to receive TT-E (Tokenized Trial Equity) tokens representing equity positions in clinical trials. Each trial launches its own fractionalized NFT.
Returns to Treasury
Value Flows Back
A portion of net profits from funding deals flows to the Treasury, creating sustainable value for the ecosystem.
Reinvest & Reward
Community Benefits
Treasury performs buybacks, airdrops, and new funding rounds, rewarding the AXC community and driving growth.
Token
Architecture
Four distinct tokens powering a compliant, transparent clinical research ecosystem
TT-E (Tokenized Trial Equity)
Digital fractional equity in clinical trials issued through Special Purpose Vehicles (SPVs). Available exclusively to accredited investors under Reg D / Reg S.
- •Represents equity ownership in trial SPVs
- •Accredited investors only (Reg D / Reg S)
- •Potential returns tied to trial success and exits
- •Transparent on-chain tracking
TT-G (Tokenized Trial Governance)
Non-equity governance token enabling community members to prioritize trials, vote on Foundation initiatives, and guide ecosystem direction. No investment returns.
- •Vote on trial prioritization and funding
- •Participate in governance proposals
- •Non-equity, non-securities token
- •Earned through AXC staking and participation
AXC (AxellaCoin)
Primary ecosystem utility token for staking, access rights, rewards distribution, and platform alignment. Powers all interactions within the AxellaCoin ecosystem.
- •Stake for governance rights (TT-G)
- •Access to CRO services (future)
- •Treasury buybacks and rewards
- •Ecosystem utility and alignment
cUSD-Clinical (Clinical Stablecoin)
USD-pegged stablecoin used for all vendor payments and trial disbursements. Ensures predictable cash flows, clean accounting, and regulatory compliance.
- •1:1 USD peg for stability
- •All vendor and trial payments
- •Transparent, auditable flows
- •Optional AXC rewards for Pioneer Vendors
Stable, Compliant
Payment Rails
Vendor and trial payments via cUSD-Clinical, our USD-pegged stablecoin for clinical research.
Predictable Payments
USD-pegged stability eliminates volatility for vendors and researchers
Clean Accounting
Simplified tax reporting and transparent tracking
Auditable Flows
On-chain transparency for every transaction
How It Works
Trial Funding Approved
Milestone-based payments in cUSD-Clinical
Vendors Get Paid
Stable USD-equivalent payments to CROs and labs
Pioneer Rewards
Optional AXC acceptance for ecosystem alignment
1:1 USD Peg: Reserve-backed for stable value.
New Era for
Clinical Funding
Dual structure balancing profit-driven growth with mission impact
Axella Treasury
For-Profit Entity
- •Holds TT-E proceeds and exit gains
- •Executes AXC buybacks and reinvestment
- •Operates under governance policy
Axella Foundation
Non-Profit Entity
- •Deploys grants under TT-G guidance
- •Vets trials for scientific rigor
- •Supports open-science initiatives
Join the
Ecosystem
Multiple pathways to participate in the future of clinical research
Researchers
Apply for milestone-based funding in cUSD-Clinical for your clinical trials
Request FundingInvestment Opportunities
Illustrative projects; replace with live listings. Eligibility depends on jurisdiction and KYC.
Pancreatic Cancer
Targeting KRAS G12D; endpoints: PFS/OS with 12-month follow-up
Alzheimer's Discovery
Novel small-molecule modulating microglial activation; IND-enabling studies
DMD Gene Therapy
AAV9 delivery for dystrophin restoration; safety/PK primary endpoints
Transparency Dashboard
Real-time on-chain metrics via Blockfrost API
Live data sourced from on-chain at launch
Governance
Three-Layer System
Transparent decision-making at every level
Community Governance (AXC)
AXC token holders participate in key ecosystem decisions
- •Vote on trial funding proposals
- •Approve new research categories
- •Set community treasury allocations
- •Propose ecosystem improvements
Stake & Support
Exclusive Benefits
Earn rewards and access exclusive content by staking AXC tokens
AMA with Lead Researcher
Monthly sessions with PIs leading funded trials
Biotech Investing 101
Educational webinars on clinical trial economics
Private Supporter Cohort
Exclusive Discord for stakers and NFT holders
Community Bounties
Earn rewards for content creation and outreach
Milestone Showcase Events
Quarterly virtual events celebrating trial progress
Early & Gated Information
Pre-announcement access to new trial opportunities
Meet the Team Behind
AxellaCoin
Core Team
Avi Kamelhar
Founder & CEO
Seasoned entrepreneur and technology leader with extensive experience in blockchain, DeFi, and healthcare innovation. Avi brings a unique blend of business acumen and technical expertise to drive AxellaCoin's vision of democratizing medical research funding.
Henry Hazan
CTO & Co-Founder
Expert blockchain architect and full-stack developer with deep expertise in smart contract development, tokenomics, and decentralized systems. Henry leads the technical architecture and implementation of the AxellaCoin ecosystem.
Medical Advisors
Judd Boczko, MD
Medical Advisor
- •Board-certified urologist with 25+ years clinical experience
- •Specializes in robotic and minimally invasive treatments
- •Led multiple clinical trials
- •Chief Investment Officer at Overlook Research & Investments
- •Reviews grant proposals and guides trial strategy
Our Journey to
Revolutionize Funding
Platform Development
Q4 2025
Building smart contracts, governance mechanisms, and user interfaces
Platform Launch
Q1 2026
Launch AXC token on Cardano and open platform to researchers
First Clinical Trials
Q2 2026
Fund first compassionate use protocols through community voting
Global Expansion
Q4 2026
Expand to support institutions in Europe and Asia
Legal Disclaimer
Important information about token structure, compliance, and regulatory framing
Token Classification
AXC (AxellaCoin) - Utility Token
AXC is a utility token for ecosystem access and alignment. It does not represent equity, ownership, or profit rights. Acquire AXC to access the ecosystem and participate in TT-G-based governance.
TT-E (Tokenized Trial Equity) - Securities Token
TT-E represents digital fractional equity in clinical trial SPVs. Available exclusively to accredited investors under Reg D / Reg S. This is a regulated security offering with potential investment returns tied to trial success.
TT-G (Tokenized Trial Governance) - Governance/Utility Token
TT-G is a non-equity governance token enabling community members to vote on trial priorities and Foundation initiatives. It does not represent securities and provides no investment returns.
cUSD-Clinical - Stablecoin Payment Rail
cUSD-Clinical is a USD-pegged stablecoin used exclusively for vendor payments and trial disbursements. It provides stable, predictable payment flows with transparent on-chain tracking.
Utility Purposes Only:
- •Support for trial funding initiatives
- •Participation in Stake-to-Support campaigns
- •Access to CRO services (future phase)
- •Governance participation via DAO (future)
When AXC is used to fund biotech startups, any resulting equity, warrants, or royalties are held by Axella Research or an affiliated treasury. These assets are not distributed to token holders, but may be used to reinvest in future research.
This structure enables a sustainable funding ecosystem—not a profit-sharing scheme.
The value of AXC may fluctuate. By using AXC, you acknowledge that it is a utility token, not a financial instrument, and is used at your own discretion.